相关实验视频

Updated: Jun 13, 2026

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

血同位素作为肌缩侧面硬化症候选生物标志物

Rogan G Magee¹, Vivianna M Van Deerlin², Corey T McMillan^1,3

¹Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Neurology. Genetics

|March 13, 2026

概括

在等离子体中分析异构R档案显示出用于诊断肌缩侧面硬化症 (ALS) 的前景. 这些microRNA变体 (isomiRs) 为ALS检测提供了比标准的microRNA (miRNA) 更好的分类准确性.

科学领域:

生物化学生物化学
基因组学就是基因组学.
生物标志物发现发现

背景情况:

肌缩侧面硬化症 (ALS) 目前缺乏FDA批准的诊断生物标志物.
微RNAs (miRNAs) 是关键的调节者,它们的变体,异构Rs,可能提供不同的诊断潜力.
TDP-43蛋白病理与miRNA处理有关,这表明异构Rs在ALS中的作用.

研究的目的:

为了研究是否循环的异构R型在患有ALS的患者中有所不同.
为了确定异构Rs是否优于miRNAs来分类ALS.
探索异构Rs作为ALS生物标志物的诊断实用性.

主要方法:

来自14名ALS患者和14名对照组的血RNA被测序.
一个定制管道处理了测序数据以识别异构R和miRNA.
XGBoost分类器使用异构Rs (模型1) 和miRNAs (模型2) 进行ALS分类的训练.

主要成果:

在ALS和对照样本之间差异表达的异构Rs明显多于miRNAs.
模型1 (异构Rs) 在血和血清中实现了0.87的AUC,用于对ALS进行分类.
模型2 (miRNAs) 在血中对ALS进行分类时表现不佳 (AUC = 0.49).

结论:

个别的异构Rs显示出作为ALS诊断的优越生物标志物的潜力.
循环异构R分析可能会提高ALS生物标志物发现的非编码RNA的性能.
进一步研究异构Rs可能会导致改善ALS的诊断工具.

更多相关视频

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...